NCT05359016
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
Active, Not Recruiting
NAAges 30–49InterventionalScreeningM.D. Anderson Cancer CenterInvestigator-initiated
~9,014 participants
Updated 2026-05-22 on ClinicalTrials.gov
What's tested:HPV testing of women for cervical cancer screening
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of women who will undergo Cervical Cancer Screening by HPV testing
Measured over through study completion, an average of 1 year
Conditions
Where it's being run
1 sites across 1 statesTexas1
Study leadership
- Kathleen Schmeler, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Women 30 - 49 years or all women living with HIV
Not currently pregnant
Patients with a cervix (women who have undergone a total hysterectomy with removal of the cervix are not eligible)
Living in Maputo or Gaza
Willing and able to provide informed consent for services.
Physical or mental impairment that inhibits participation in the study
Pregnant women
What this trial measures
- Number of women who will undergo Cervical Cancer Screening by HPV testingthrough study completion, an average of 1 year